Jazz pharmaceuticals stocks
JAZZ | Complete Jazz Pharmaceuticals PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. DUBLIN, Sept. 25, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (JAZZ) announced today that positive data from the Phase 3 study of its investigational medicine, JZP-258, for the treatment of cataplexy and excessive daytime sleepiness (EDS) in adults with narcolepsy were presented at World Sleep 2019 in Vancouver, Canada. Jazz Pharmaceuticals plc Common Stock (Ireland) (JAZZ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.